15-year metastasis-free survival in men on active surveillance in The Netherlands

According to new data reported at the annual meeting of the European Association of Urology in London, active surveillance of men diagnosed with low-risk prostate cancer was not associated with an elevated risk for metastatic disease at 15 years of follow-up. … READ MORE …

Clinical trial design, clinical advice to patients, and clinical decision-making: not the same thing at all

In a recent opinion piece in the Journal of Clinical Oncology, Dr. Anthony D’Amico (a prostate cancer specialist for whom we have great respect) has again aired his concerns about risk for progression to metastatic disease among men on active surveillance. … READ MORE …

Serial mpMRIs instead of serial biopsies for men on active surveillance

The role of baseline and repeat multiparametric MRI (mpMRI) scanning as a substitute for repeat biopsies in the initial evaluation and ongoing management of men on active surveillance continues to evolve. … READ MORE …

Informing the media community about prostate cancer and its management

A new article on the HealthNewsReview web site addresses issues related to the diagnosis of prostate cancer and the management of low-risk forms of the disease using active surveillance. … READ MORE …

Another systemic failure of care and about whether anyone cared at all

Sometimes it’s easier to blame the patient than it is to blame the medical system, and so that’s what people often do. But if one is going to blame the patient, then one really ought to have data to back it up. … READ MORE …

The ASCO Genitourinary Cancers Symposium: a brief report

Your sitemaster is gradually “coming back to life” after a rather unpleasant week that included his trip to the GU Cancers Symposium (when he should probably have been in his bed at home). So here is the quick summary from Orlando. … READ MORE …

And now for an update from Howard Wolinsky

Prostate Cancer International is very proud to have been part (through PCPC3) of helping to have a patient participate in the very first session of the recent Genitourinary Cancers Symposium in Orlando, Florida (which was all about active surveillance and its application). … READ MORE …